Advertisement
Advertisement

SMMT

SMMT logo

Summit Therapeutics Inc. Common Stock

18.63
USD
-0.03
-0.17%
Oct 30, 16:00 UTC -4
Closed
exchange

After-Market

18.73

+0.10
+0.52%

Summit Therapeutics Inc. Common Stock Profile

About

Summit Therapeutics PLC is engaged in the discovery and development of drug to treat the fatal muscle wasting disease Duchenne Muscular Dystrophy and infections caused by the bacteria C. difficile. Summit Therapeutics PLC is headquartered in Abingdon, the United Kingdom.

Info & Links

CEO

Robert W. Duggan

Headquarters

601 BRICKELL KEY DRIVE, SUITE 1000
MIAMI, FL 33131, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.summittxinc.com

Auditor

PricewaterhouseCoopers LLP

Share holders

139

Employees

159

Summit Therapeutics Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

13.94B

Enterprise Value

13.64B

Enterprise Value/EBITDA(ttm)

-17.97

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

74.46

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-311.15%

Return on Invested Capital(ttm)

-264.91%

Return on Assets(ttm)

-262.35%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-759.18M

Net Income Available to Common(ttm)

-746.08M

Diluted EPS(ttm)

-1.24

Share Statistics

Beta (5Y Monthly)

-1.13

52-Week Change

-14.67%

S&P 500 52-Week Change

19.58%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

742.85M

Dividend Yield

0.00%

Float4

112.41M

% Held by Insiders

84.90%

% Held by Institutions

4.61%

Balance Sheet

Total Cash(mrq)

298.19M

Total Cash Per Share(mrq)

0.40

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

5.13%

Quick Ratio(mrq)

3.80%

Book Value Per Share(mrq)

0.35

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.17

Free Cash Flow(ytd)

-128.33M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement